与药物相关的影响儿童骨健康
Charu Jain1, Luca Valdivia1, Laurel Wong1
1Icahn School of Medicine at Mount Sinai, Department of Orthopaedics, New York, NY, USA.
Journal of the Pediatric Orthopaedic Society of North America
|October 13, 2025
概括
许多常见的儿科药物可能会损害骨发育,增加骨折风险. 双酸盐可以帮助加强高风险儿童的骨,但谨慎管理对于终身骨健康至关重要.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 药理学 药理学是指药理学的学科.
- 骨的新陈代谢 骨的新陈代谢
背景情况:
- 童年和青春期对于发展峰值骨质量至关重要.
- 通常给儿童开的药物可能会对骨发育和健康产生负面影响.
- 在这些形成年间的干扰会导致终身的骨问题.
研究的目的:
- 审查用于儿科患者群体的药物对骨的影响.
- 强调长期服用药物的儿童骨健康监测的重要性.
- 为医疗保健提供者提供关于药物诱导的骨变化的风险和管理策略的信息.
主要方法:
- 关于儿科骨健康和药物影响的研究文献综述.
- 分析儿科药物影响骨代谢的机制.
- 对儿童药物诱导的骨损失的治疗干预措施的评估.
主要成果:
- 常见的儿科药物 (如葡萄皮质类药物,抗药物) 可以降低骨矿物质密度 (BMD),损害生长,增加骨折风险.
- 药物诱导的骨损失包括骨质母细胞活性受损,营养代谢改变和荷尔蒙干扰.
- 双酸盐在增加骨质量和减少小儿骨质疏松症骨折方面表现出有效性,但需要仔细监督.
结论:
- 儿科医生必须识别有风险的儿童,并实施骨健康的预防策略.
- 优化营养,体力活动和查是关键的预防措施.
- 医疗保健提供者之间的合作对于治疗慢性药物治疗儿童的骨健康管理至关重要.
更多相关视频
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Excretion
212
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
242
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
242
Pharmacokinetics in Pediatric Patients: Drug Metabolism
192
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
192
Pharmacokinetics in Pediatric Patients: Drug Distribution
252
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
252
Bone Disorders
5.1K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.1K
Drug Dosing: Infants and Children
253
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
253


